Misplaced Pages

This is an old revision of this page, as edited by Whywhenwhohow (talk | contribs) at 05:51, 21 December 2024 (add legal, names). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Ilunocitinib, sold under the brand name Zenrelia, is a veterinary medication used for the treatment of pruritus (itching) in dogs.

Ilunocitinib was approved for medical use in the United States in September 2024, and in Canada in December 2024.

Medical uses

Ilunocitinib is indicated for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least twelve months of age.

Contraindications

It is not safe to administer vaccines to dogs that are concurrently receiving ilunocitinib.

Society and culture

Legal status

Ilunocitinib was approved for medical use in the United States in September 2024, and in Canada in December 2024.

Names

Ilunocitinib is the international nonproprietary name.

Ilunocitinib is sold under the brand name Zenrelia.

References

1. ^ "Notice: Multiple additions to the Prescription Drug List (PDL) [2024-12-20]". Health Canada. 20 December 2024. Retrieved 21 December 2024. Text was copied from this source. Reproduction is authorized provided the source is acknowledged.
2. "Zenrelia". U.S. Food and Drug Administration (FDA). Retrieved 21 December 2024.
3. ^ https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/15865
4. "FDA Approves New Treatment for Allergic Skin Conditions in Dogs". U.S. Food and Drug Administration (FDA). 19 September 2024. Retrieved 21 December 2024. This article incorporates text from this source, which is in the public domain.
5. ^ "Dear Veterinarian Letter regarding important safety information associated with the use of Zenrelia (ilunocitinib tablets) for controlling pruritus associated with allergic dermatitis and atopic dermatitis in dogs". U.S. Food and Drug Administration (FDA). 1 October 2024. Retrieved 21 December 2024. This article incorporates text from this source, which is in the public domain.
6. "Recent Animal Drug Approvals". U.S. Food and Drug Administration. 1 October 2024. Retrieved 21 December 2024.
7. World Health Organization (2022). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 87". WHO Drug Information. 36 (1). hdl:10665/352794.

• Medicine

This veterinary medicine–related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Drugs not assigned an ATC code
• Dog medications
• Immunosuppressants
• Janus kinase inhibitors
• Veterinary medicine stubs